Advertisement

Topics

Vivus Company Profile

00:59 EST 25th November 2017 | BioPortfolio

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annually. VIVUS has three products that are positioned to enter Phase 3 clinical trials and one product currently under NDA review by the FDA. The investigational pipeline includes: Qnexa™, for which a Phase 2 study has been completed for the treatment of obesity; Testosterone MDTS®, for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist™, for which a Phase 3 study has been completed and an NDA submitted for the treatment of menopausal symptoms; avanafil, for which a Phase 2 study has been completed for the treatment of erectile dysfunction (ED); and, MUSE®, which is approved and currently on the market for the treatment of ED.

Location

1172 Castro Street
Mountain View
CA
94040
United States of America

Contact

Phone: 650 934 5200


News Articles [24 Associated News Articles listed on BioPortfolio]

Reviewing VIVUS

VIVUS and Fortress Biotech are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, v...

Vivus, Dr. Reddy's settle patent litigation relating to Qsymia

Vivus Inc. and Dr. Reddy's Laboratories Ltd. have settled patent litigation surrounding Vivus' weight management product Qsymia (phentermine and topiramate extended-release capsules). The litigation h...

EMA grants orphan status to VIVUS' PAH drug

VIVUS' tacrolimus was granted orphan drug designation by the European Medicines Agency as a treatment for patients with pulmo -More- 

Coming In Monday's "The Pink Sheet" DAILY - EMA Panel Again Rejects Vivus' Obesity Drug Qsiva

European Medicines Agency committee recommends Vivus' Qsiva not be approved - Financings of the Fortnight looks at pending IPOs - Kolltan Pharmaceuticals prepares to move to new stage - Compounding ph...

VIVUS to Host Third Quarter Business Update and Financial Results Conference Call on Tuesday, November 7, 2017

CAMPBELL, CA--(Marketwired - October 31, 2017) - VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results and provide a business update for the third quarter of 2017 after the...

VIVUS to Present at 2017 Wells Fargo Healthcare Conference on September 7, 2017

CAMPBELL, CA--(Marketwired - August 22, 2017) - VIVUS,Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company committed to the development and commercialization of innovative therapies focus...

Vivid Potential Victory With Vivus, Inc. Convertible Bonds

VIVUS Settlement Could Clue In Orexigen Investors

  Life Sciences Jobs   ...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Muse [VIVUS, Inc.]

MUSE(alprostadil) urethral suppository

Muse [Meda Pharmaceuticals Inc.]

MUSE (alprostadil) suppository[VIVUS, Inc.]

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Multi-Center Study to Evaluate Estradiol Transdermal Spray in the Treatment of Symptomatic Postmenopausal Women

Estradiol treatment is effective at reducing vasomotor symptoms (eg, hot flushes) in postmenopausal women. Vivus has a proprietary spray delivery system (Evamist) for estradiol. This stu...

Companies [3 Associated Companies listed on BioPortfolio]

VIVUS, Inc.

VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development, QNEXA®, has completed p...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the pot...

Aventyn, Inc.

Aventyn is the first company to deliver innovative secure connected information processing solutions with its standards based CLIP® solution to efficiently manage health inform...

More Information about "Vivus" on BioPortfolio

We have published hundreds of Vivus news stories on BioPortfolio along with dozens of Vivus Clinical Trials and PubMed Articles about Vivus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vivus Companies in our database. You can also find out about relevant Vivus Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record